Table 5.
Regressor | Baseline | Follow-up | β visit | β clinical | β visit*clinical |
---|---|---|---|---|---|
DKEFS Stroop III | 122.20 ± 29.92 | 140.69 ± 39.79 | −0.70 | −0.12 | 0.39 |
DKEFS Stroop IV | 137.28 ± 29.77 | 159.33 ± 45.59 | −0.59 | −0.38 | 0.49 |
RBD | 11/16 | −0.69 | −0.89 |
β coefficients are presented for selected AIC minimizing model. If the independent effect model was selected, β coefficients for independent effect of visit (βvisit) and clinical regressor (βclinical) are presented. If the interaction model was selected, β coefficients for the marginal effect of visit (βvisit), marginal effect of clinical regressor (βclinical) and visit by clinical regressor interaction term (βvisit*clinical) are presented. Statistically significant model effects (P < 0.05) are bolded. Descriptive statistics for the clinical regressors are presented for baseline and follow-up visit as mean ± SD for Stroop measures and as ratio of participants for RBD. DKEFS = Delis–Kaplan Executive Function System; RBD = rapid eye movement sleep behaviour disorder.